APR 11, 2016 10:11 AM PDT

Optical Sensor 1 Million Times More Sensitive at Cancer Detection

WRITTEN BY: Xuan Pham
New nanotechnology design offers unprecedented cancer sensitivity
In an effort to improve sensitivity for cancer detection, engineers at the Case Western Reserve University have achieved a device that can pick up a single molecule produced from cancer cells. This optical sensor is purported to be 1 million times more sensitive than the best liquid biopsy technology currently on the market – a bold claim for a bold innovation, indeed.
 
"The prognosis of many cancers depends on the stage of the cancer at diagnosis," said Giuseppe Strangi, professor of physics at Case Western Reserve, and lead study author. In fact, about 90% of cancer deaths are attributed to metastatic events. Thus, prompt detection of cancer presence could increase survival rates dramatically. As such, liquid biopsies to screen for presence of circulating tumor DNA (ctDNA) has been developed, but the technology is often questioned for accuracy.
 
Instead of relying on sequence variations to diagnose cancer presence, the new research hinges on detecting actual enzyme molecules released by cancer cells. The biosensor acts as a “biological sieve” that can isolate proteins that weigh less than 800 quadrillionths of a nanogram from an extremely dilute solution.
 
"Very early, most circulating tumor cells express proteins of a very low molecular weight, less than 500 Daltons," said Strangi. "These proteins are usually too small and in too low a concentration to detect with current test methods, yielding false negative results.”
 
 

To achieve their unprecedented sensitivity, the team coupled nanotechnology with microfluidic channels, whose surfaces were lined with a metamaterial – the team’s newly innovated material that can capture very small molecules. This design bypassed some previous limitations for detection, namely that light waves can’t detect particles smaller than about half a micron. Moreover, molecules in fluid motion are unlikely to attach to a sensor’s surface by chance. In their design, the particles are pulled into the microfluidic channel and are driven straight to the metamaterial’s sensing surface.
 
"It's extremely sensitive," Strangi says. "When a small molecule lands on the surface, it results in a large local modification, causing the light to shift." Every shift or reflection of light waves is an indicator of the molecules’ identity. Thus, by patterning the light shifts with certain molecules, the team hopes to create a biomarker profile for different cancers, enabling detection of many types of diseases.
 
"With this platform, we've detected proteins of 244 Daltons, which should enable doctors to detect cancers earlier--we don't know how much earlier yet," said Strangi. "This biosensing platform may help to unlock the next era of initial cancer detection."
 
The biosensor has broad applications for all cancer types, but most immediately for certain lethal cancers, such as pancreatic and bowel cancers, that are often not diagnosed by other means until too late. With the new biosensor, which fits in a doctor’s palm, minute amounts of cancer-specific proteins can be detected from the patient’s blood. This can prompt rapid treatment to dramatically improve a patient’s survival odds.
 
Furthermore, the researchers hope the tool will expand our current knowledge of cancer biology. "This new sensing technology may help us not only detect cancers, but what subset of cancer, what's driving its growth and spread and what it's sensitive to," said Nima Sharifim the Kendrick Family Chair for Prostate Cancer Research at the Cleveland Clinic. "The sensor, for example, may help us determine markers of aggressive prostate cancers, which require treatments, or indolent forms that don't."

Additional sources: MNT, Science Daily
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 11, 2020
Cancer
Targeting Senescence in the Peripheral Nervous System to Fight Toxicity
SEP 11, 2020
Targeting Senescence in the Peripheral Nervous System to Fight Toxicity
Chemotherapy is a life-saving discovery for cancer patients. One of its biggest drawbacks is the toxicity that comes wit ...
SEP 22, 2020
Cardiology
Investigating the Mechanism Behind 5-Fluorouracil's Cardiotoxicity
SEP 22, 2020
Investigating the Mechanism Behind 5-Fluorouracil's Cardiotoxicity
Cancer therapies have come quite far, with several options available for many cancers. An issue that has plagued many of ...
OCT 18, 2020
Cancer
Virus-mimicking drug attacks melanoma tumors
OCT 18, 2020
Virus-mimicking drug attacks melanoma tumors
Research published recently in the journal Science Translational Medicine from scientists at the UCLA Jonsson Compr ...
NOV 07, 2020
Cancer
Newly identified biomarker sheds light on antiangiogenic drug responses
NOV 07, 2020
Newly identified biomarker sheds light on antiangiogenic drug responses
A study published last week in the journal EMBO Molecular Medicine provides insight into the molecular mechanisms t ...
NOV 16, 2020
Cancer
Fingerprinting Ginger Extracts and Testing Their Anti-Cancer Abilities
NOV 16, 2020
Fingerprinting Ginger Extracts and Testing Their Anti-Cancer Abilities
Modern medicine relies on careful study and isolation of compounds or proteins, but many studies point to natural herbal ...
NOV 24, 2020
Clinical & Molecular DX
Young Inventor Creates Award-winning At-home Cancer Diagnostic
NOV 24, 2020
Young Inventor Creates Award-winning At-home Cancer Diagnostic
Getting a breast cancer diagnosis often means having to endure multiple tests, including some painful and invasive proce ...
Loading Comments...